Skip to content
  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJNeurology
    • VJRegenmed
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Biomarkers
    Treatment
    Clinical Care
    Prevention
    View all Topics
  • Conferences
    AAIC 2023
    BNA 2023
    AD/PD 2023
    ARUK 2023
    CTAD 2022
    AAIC 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Suzanne Hendrix

Efficient use of open label extension data 1:31
Efficient use of open label extension data
Suzanne Hendrix • 19 Jul 2023
Time saved with Alzheimer’s disease therapeutics 4:29
Time saved with Alzheimer’s disease therapeutics
Suzanne Hendrix • 19 Jul 2023
Time saved in Alzheimer’s disease in Phase III trial of donanemab 0:49
Time saved in Alzheimer’s disease in Phase III trial of donanemab
Suzanne Hendrix • 19 Jul 2023
Measuring cognitive impairment in early Alzheimer’s disease 1:16
Measuring cognitive impairment in early Alzheimer’s disease
Suzanne Hendrix • 19 Jul 2023
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease 2:34
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease
Suzanne Hendrix • 21 Mar 2023
The power of composite tests to track Alzheimer’s disease progression 3:48
The power of composite tests to track Alzheimer’s disease progression
Suzanne Hendrix • 21 Mar 2023
Trends in the use of surrogate biomarkers during clinical trials 3:25
Trends in the use of surrogate biomarkers during clinical trials
Suzanne Hendrix • 21 Mar 2023
Futility analysis in clinical trials: practical and ethical considerations 1:39
Futility analysis in clinical trials: practical and ethical considerations
Suzanne Hendrix • 21 Mar 2023
Symptomatic versus disease modifying treatments 0:59
Symptomatic versus disease modifying treatments
Suzanne Hendrix • 21 Mar 2023
Distinguishing between disease modifying and symptomatic effects in clinical trials 2:46
Distinguishing between disease modifying and symptomatic effects in clinical trials
Suzanne Hendrix • 21 Mar 2023
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy